| abstract |
The present invention relates to the field of diagnostic measures. Specifically, it relates to a method for diagnosing whether a pregnant subject suffering from preeclampsia or having a predisposition therefor is at risk of experiencing a premature termination of pregnancy, or not, said method comprising the steps of determining the amount of PlGF and GDF-15 and, preferably, sFlt1 in a sample of the said subject and comparing the determined amounts to reference amounts for PlGF and GDF-15 and, preferably, sFlt1, whereby an increased risk of experiencing premature termination of pregnancy is to be diagnosed. Further encompassed is a diagnostic device and a kit for carrying out the aforementioned method. |